LGNYZLIGAND PHARMACEUTICALS INCvs its industry peers
A metric-by-metric comparison of LIGAND PHARMACEUTICALS INC against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LGNYZEsta | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#2 | 12.9%#1 | 3.0%#1 | — | — | — |
| KMDA | $511M#5 | — | — | 9.5x#3 | -19.7%#8 | 39.7%#7 | 48.9%#1 | — | — | — | 29.9%#2 | 2.3%#1 |
| KNSA | $5.9B#3 | 84.9x#1 | 9.8x#3 | 8.7x#2 | 60.1%#6 | 236.6%#5 | 11.4%#6 | 9.7%#5 | — | — | 115.3%#1 | — |
| KPHMW | — | — | — | — | -100.0%#10 | -401.4%#10 | — | -0.1%#6 | -127.6%#5 | — | — | — |
| KZIA | $8.4B#1 | — | — | — | — | — | — | — | — | — | 26.5%#3 | — |
| LEGN | $6.5B#2 | — | 6.4x#1 | 6.3x#1 | 64.0%#1 | -67.7%#9 | -13.3%#8 | -29.2%#7 | — | — | -49.9%#5 | — |
| LGNDZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#2 | 12.9%#1 | 3.0%#1 | — | — | — |
| LGNXZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#2 | 12.9%#1 | 3.0%#1 | — | — | — |
| LGNZZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#2 | 12.9%#1 | 3.0%#1 | — | — | — |
| LGVN | $69M#6 | — | 6.7x#2 | 57.9x#4 | -49.9%#9 | -42.1%#8 | -1942.2%#9 | -218.3%#9 | -4923.3%#6 | — | -67.3%#6 | — |
| LIANY | — | — | — | — | — | 43.8%#6 | — | -54.5%#8 | — | — | — | — |
| LIFD | — | — | — | — | -1.1%#7 | -1238.3%#11 | 2.5%#7 | -353.7%#10 | — | — | — | — |
| LKFT | $1.9B#4 | — | — | — | — | — | — | — | — | — | -14.0%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice